Accelerate Coronavirus Disease 2019 (COVID-19) Vaccine Rollout by Delaying the Second Dose of mRNA Vaccines.
作者信息
Plotkin Stanley A, Halsey Neal
机构信息
University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Johns Hopkins University Bloomberg School of Public Health, Bloomberg School of Public Health, Baltimore, Maryland, USA.
出版信息
Clin Infect Dis. 2021 Oct 5;73(7):1320-1321. doi: 10.1093/cid/ciab068.
Abstract
摘要
相似文献
1
Accelerate Coronavirus Disease 2019 (COVID-19) Vaccine Rollout by Delaying the Second Dose of mRNA Vaccines.通过推迟mRNA疫苗的第二剂接种来加速2019冠状病毒病（COVID-19）疫苗的推广。
Clin Infect Dis. 2021 Oct 5;73(7):1320-1321. doi: 10.1093/cid/ciab068.
2
Effectiveness of Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Cohort of Healthcare Personnel.信使 RNA 新冠病毒 2019 疾病（COVID-19）疫苗对医护人员队列中严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）感染的有效性。
Clin Infect Dis. 2021 Sep 15;73(6):e1376-e1379. doi: 10.1093/cid/ciab361.
3
The initial impact of a national BNT162b2 mRNA COVID-19 vaccine rollout.全国性 BNT162b2 mRNA COVID-19 疫苗接种计划的初步影响。
Int J Infect Dis. 2021 Jul;108:116-118. doi: 10.1016/j.ijid.2021.05.021. Epub 2021 May 13.
4
The Case Against Delaying Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccine Boosting Doses.反对延迟严重急性呼吸综合征冠状病毒2（SARS-CoV-2）信使核糖核酸（mRNA）疫苗加强针接种的理由
Clin Infect Dis. 2021 Oct 5;73(7):1321-1323. doi: 10.1093/cid/ciab070.
5
Positive aspects of the mRNA platform for SARS-CoV-2 vaccines.mRNA 平台在 SARS-CoV-2 疫苗方面的积极方面。
Hum Vaccin Immunother. 2021 Aug 3;17(8):2445-2447. doi: 10.1080/21645515.2021.1900713. Epub 2021 Apr 8.
6
How important is the second dose of the COVID-19 mRNA vaccine?新冠病毒mRNA疫苗的第二剂有多重要？
J Allergy Clin Immunol Pract. 2021 Jun;9(6):2537. doi: 10.1016/j.jaip.2021.02.061.
7
Single Dose of an mRNA Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) Vaccine Is Associated With Lower Nasopharyngeal Viral Load Among Nursing Home Residents With Asymptomatic Coronavirus Disease 2019 (COVID-19).mRNA 单价 SARS-CoV-2 疫苗接种一剂可降低无症状 2019 冠状病毒病（COVID-19）养老院居民鼻咽部病毒载量。
Clin Infect Dis. 2021 Sep 15;73(6):e1365-e1367. doi: 10.1093/cid/ciab263.
8
Acute Perimyocarditis Following First Dose of mRNA Vaccine Against COVID-19.接种第一剂新冠病毒mRNA疫苗后发生的急性心包心肌炎
Dtsch Arztebl Int. 2021 Aug 9;118(31-32):546. doi: 10.3238/arztebl.m2021.0288.
9
Preliminary evidence of blunted humoral response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients treated with ocrelizumab.奥瑞珠单抗治疗多发性硬化症患者对 SARS-CoV-2 mRNA 疫苗的体液反应迟钝的初步证据。
Neurol Sci. 2021 Sep;42(9):3523-3526. doi: 10.1007/s10072-021-05397-7. Epub 2021 Jun 15.
10
Coronavirus disease 2019 (COVID-19) mRNA vaccine effectiveness in asymptomatic healthcare workers.2019冠状病毒病（COVID-19）mRNA疫苗对无症状医护人员的有效性
Infect Control Hosp Epidemiol. 2021 Dec;42(12):1517-1519. doi: 10.1017/ice.2021.287. Epub 2021 Jun 24.
引用本文的文献
1
Should we allocate more COVID-19 vaccine doses to non-vaccinated individuals?我们应该给未接种疫苗的人分配更多的新冠疫苗剂量吗？
PLOS Glob Public Health. 2022 Jul 1;2(7):e0000498. doi: 10.1371/journal.pgph.0000498. eCollection 2022.
2
Revisiting COVID-19 policies: 10 evidence-based recommendations for where to go from here.重新审视 COVID-19 政策：接下来该怎么做的 10 项基于证据的建议。
BMC Public Health. 2021 Nov 13;21(1):2084. doi: 10.1186/s12889-021-12082-z.
3
Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccination.Fab 和 Fc 有助于对 SARS-CoV-2 进行最大程度的保护，采用 Matrix-M 疫苗的 NVX-CoV2373 亚单位疫苗。
Cell Rep Med. 2021 Sep 21;2(9):100405. doi: 10.1016/j.xcrm.2021.100405. Epub 2021 Aug 31.
4
Prioritizing the First Doses of SARS-CoV-2 Vaccine to Save the Elderly: The Case Study of Italy.优先为老年人接种 SARS-CoV-2 疫苗以拯救老年人：意大利的案例研究。
Front Public Health. 2021 Jul 14;9:684760. doi: 10.3389/fpubh.2021.684760. eCollection 2021.
5
Modeling the Impact of COVID-19 Vaccination in Lebanon: A Call to Speed-Up Vaccine Roll Out.模拟新冠疫苗接种在黎巴嫩的影响：呼吁加速疫苗推广
Vaccines (Basel). 2021 Jun 25;9(7):697. doi: 10.3390/vaccines9070697.
6
Maximization of Open Hospital Capacity under Shortage of SARS-CoV-2 Vaccines-An Open Access, Stochastic Simulation Tool.严重急性呼吸综合征冠状病毒2型疫苗短缺情况下开放医院容量的最大化——一种开放获取的随机模拟工具
Vaccines (Basel). 2021 May 22;9(6):546. doi: 10.3390/vaccines9060546.
Zotero 插件